BI 3034701 for obesity

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 23 Jun 2026: Trial registered, NCT07662122
  2. 30 Jun 2026: Trial started, NCT07662122

The trials

NCT07662122: A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

State
Under way
Phase
Phase 2
People
345 taking part
Started
30 Jun 2026
Primary completion
26 Jun 2027
Arms
BI 3034701 treatment group 1, BI 3034701 treatment group 2, BI 3034701 treatment group 3, BI 3034701 treatment group 4, BI 3034701 treatment group 5, BI 3034701 treatment group 6
Results
None posted
  1. 23 Jun 2026: Trial registered
  2. 30 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.